Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

508 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.
Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ; VIGOR Study Group. Bombardier C, et al. Among authors: hochberg mc. N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103. N Engl J Med. 2000. PMID: 11087881 Clinical Trial.
Response to expression of concern regarding VIGOR study.
Bombardier C, Laine L, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ, Weaver A. Bombardier C, et al. Among authors: hochberg mc. N Engl J Med. 2006 Mar 16;354(11):1196-9. doi: 10.1056/NEJMc066096. Epub 2006 Feb 22. N Engl J Med. 2006. PMID: 16495387 No abstract available.
A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC. Cryer BL, et al. Among authors: hochberg mc. Ann Med. 2011 Dec;43(8):594-605. doi: 10.3109/07853890.2011.625971. Epub 2011 Oct 22. Ann Med. 2011. PMID: 22017620 Clinical Trial.
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.
Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Matchaba P, Gimona A, Hawkey CJ; TARGET Study Group. Schnitzer TJ, et al. Among authors: hochberg mc. Lancet. 2004 Aug 21-27;364(9435):665-74. doi: 10.1016/S0140-6736(04)16893-1. Lancet. 2004. PMID: 15325831 Clinical Trial.
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
Farkouh ME, Kirshner H, Harrington RA, Ruland S, Verheugt FW, Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Gimona A, Matchaba P, Hawkey CJ, Chesebro JH; TARGET Study Group. Farkouh ME, et al. Among authors: hochberg mc. Lancet. 2004 Aug 21-27;364(9435):675-84. doi: 10.1016/S0140-6736(04)16894-3. Lancet. 2004. PMID: 15325832 Clinical Trial.
COX-2-selective inhibitors in the treatment of arthritis.
Schnitzer TJ, Hochberg MC. Schnitzer TJ, et al. Among authors: hochberg mc. Cleve Clin J Med. 2002;69 Suppl 1:SI20-30. doi: 10.3949/ccjm.69.suppl_1.si20. Cleve Clin J Med. 2002. PMID: 12086290 Review.
Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis.
Hochberg MC, Berry S, Broglio K, Rosenblatt L, Nadkarni A, Trivedi D, Hebden T. Hochberg MC, et al. Curr Med Res Opin. 2013 Oct;29(10):1213-22. doi: 10.1185/03007995.2013.813839. Epub 2013 Jul 25. Curr Med Res Opin. 2013. PMID: 23745516 Review.
COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
Hochberg MC. Hochberg MC. Curr Top Med Chem. 2005;5(5):443-8. doi: 10.2174/1568026054201695. Curr Top Med Chem. 2005. PMID: 15974939 Review.
Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
Hochberg MC. Hochberg MC. Am J Manag Care. 2002 Nov;8(17 Suppl):S502-17. Am J Manag Care. 2002. PMID: 12458820 Review.
Infliximab for the treatment of rheumatoid arthritis.
Blumenauer B, Judd M, Wells G, Burls A, Cranney A, Hochberg M, Tugwell P. Blumenauer B, et al. Cochrane Database Syst Rev. 2002;(3):CD003785. doi: 10.1002/14651858.CD003785. Cochrane Database Syst Rev. 2002. PMID: 12137712 Review.
508 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback